Efficacy and tolerability of methotrexate in severe childhood alopecia areata

British Journal of Dermatology

Volumn 165, Issue 2, 2011, Pages 407-410

  Royer, M ^a   Bodemer, C ^b   Vabres, P ^c   Pajot, C ^d   Barbarot, S ^e   Paul, C ^a   Mazereeuw, J ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL DU BOCAGE   (France)

^d HÔPITAL DES ENFANTS   (France)

^e Nantes Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHISOPRINOL; METHOTREXATE; METHYLPREDNISOLONE; MINOXIDIL; PREDNISOLONE; PREDNISONE; TACROLIMUS;

ALOPECIA AREATA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRANCE; HAIR GROWTH; HAIR REGROWTH; HERPES ZOSTER; HUMAN; INFANT; LABORATORY TEST; MALE; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ADOLESCENT; ALOPECIA AREATA; CHILD; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; METHOTREXATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960622141     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10383.x     Document Type: Article

References (15)

1. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975-1989. Mayo Clin Proc 1995; 70: 628-33.
2. Nanda A, Al-Fouzan AS, Al-Hasawi F,. Alopecia areata in children: a clinical profile. Pediatr Dermatol 2002; 19: 482-5. (Pubitemid 35425144)
3. Tosti A, Bellavista S, Iorizzo M,. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438-41. (Pubitemid 44189598)
4. Liakopoulou M, Alifieraki T, Katideniou A, et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997; 36: 678-84. (Pubitemid 27184076)
5. Joly P,. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol 2006; 55: 632-6. (Pubitemid 44436626)
6. Chartaux E, Joly P,. Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis. Ann Dermatol Venereol 2010; 137: 507-13.
7. Olsen EA, Hordinsky MK, Price VH, et al. National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines-Part II. J Am Acad Dermatol 2004; 51: 440-7.
8. MacDonald Hull SP, Wood ML, Hutchinson PE, et al. British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149: 692-9. (Pubitemid 37419985)
9. El-Zawahry BM, Bassiouny DA, Khella A, Zaki NS,. Five-year experience in the treatment of alopecia areata with DPC. J Eur Acad Dermatol Venereol 2010; 24: 264-9.
10. Tosti A, Guidetti MS, Bardazzi F, Misciali C,. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996; 35: 199-201.
11. Hubiche T, Léauté-Labrèze C, Taïeb A, Boralevi F,. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008; 158: 1136-7. (Pubitemid 351521428)
12. Mohamed Z, Bhouri A, Jallouli A, et al. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen. J Eur Acad Dermatol Venereol 2005; 19: 552-5. (Pubitemid 41742834)
13. Al-Mutairi N,. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 2009; 26: 547-50.
14. Gip L, Lodin A, Molin L,. Alopecia areata. A follow-up investigation of outpatient material. Acta Derm Venereol (Stockh) 1969; 49: 180-8.
15. Dadlani C, Orlow SJ,. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol 2005; 52: 316-40.